13D Filing: Broadfin Capital and Biodelivery Sciences International Inc (BDSI)
Biodelivery Sciences International Inc (NASDAQ:BDSI): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital&#......(read more)
Posts Tagged ‘Broadfin Capital’
13D Filing: Broadfin Capital and Novelion Therapeutics Inc. (NVLN)
Novelion Therapeutics Inc. (NASDAQ:NVLN): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest......(read more)
13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)
Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)
Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)
Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)
Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
13G Filing: Broadfin Capital and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13G Filing: Broadfin Capital and Cidara Therapeutics Inc. (CDTX)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13G Filing: Broadfin Capital and Corium International Inc. (CORI)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13G Filing: Broadfin Capital and Aratana Therapeutics Inc. (PETX)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13G Filing: Broadfin Capital and Alphatec Holdings Inc. (NASDAQ:ATEC)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Horizon Pharma PLC (HZNP), Flamel Technologies S.A. (ADR) (FLML) & More: Why Should You Consider Following Broadfin Capital’s Investment Moves?
At Insider Monkey, we think that an investor can beat the market by imitating smart moves of big hedge funds into the top pick they are bullish on. We......(read more)
Qlt Inc (QLTI): Broadfin Capital Adds Another 820,000 Shares to its Position
We wrote recently about Qlt Inc (NASDAQ:QLTI) entering into an Agreement and Plan of Merger with its wholly-owned indirect subsidiary, Isotope Acquisition......(read more)
Aegerion Pharmaceuticals Inc. (AEGR): Broadfin Capital Raises Its Stake Ahead of Merger
Back in June, Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Qlt Inc. and the latter’s subsidiary, Isotope Acquisition Corp., entered into an Agreement......(read more)
Qlt Inc (QLTI): Broadfin’s Kevin Kotler to Become Director of Novelion
In June, Qlt Inc (NASDAQ:QLTI) signed an Agreement and Plan of Merger with its wholly-owned indirect subsidiary, Isotope Acquisition Corp., and Aegerion......(read more)
Recro Pharma Inc. (REPH): Largest Shareholder Broadfin Capital Buys Even More Shares
An amended 13D filing with the Securities and Exchange Commission showed that Kevin Kotler‘s Broadfin Capital has acquired more shares of Recro......(read more)
Healthcare-Focused Broadfin Capital’s Notable Moves Include Cardiovascular Systems, Nevro Corp & Others
Kevin Kotler‘s healthcare-focused fund Broadfin Capital held a 13F portfolio valued at about $1.04 billion at the end of the first quarter, according......(read more)
Kevin Kotler’s Healthcare Fund Broadfin Capital Just Had A Disastrous Q1
Though 2016 hasn’t been great for the overall hedge fund industry so far, it is turning out to be an especially terrible year for biotech-focused......(read more)
13G Filing: Broadfin Capital and Cardica Inc (CRDC)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION......(read more)
Nevro Corp (NVRO): Broadfin Capital Jumps On February Swoon to Buy More Shares
Kevin Kotler‘s Broadfin Capital has filed a Form 13G disclosing an enlarged position of 1.46 million shares of Nevro Corp (NYSE:NVRO). The holding......(read more)
Billionaire Icahn Salutes Xerox Corp (XRX)’s Split, Lasry Trims YRC Worldwide Inc. (YRCW) Stake, and Kotler Buys More Raptor Pharmaceutical Corp. (RPTP)
Although the average hedge fund has been struggling to beat broader market benchmarks in recent years, the hedge fund industry as a whole has been constantly......(read more)
Bill & Melinda Gates Foundation Trust’s Latest Bet on China & Two Other Latest Hedge Fund Moves
At Insider Monkey, we focus mainly on the 13F filings of around 730 hedge funds and other institutional investors, in order to identify trading opportunities......(read more)
Starboard Trims Office Depot Stake Amid FTC Challenging Merger with Staples; Broadfin Capital Buys More Derma Sciences Inc. (DSCI)
Some bright minds of the finance world believe that shareholder activism has surged in recent years because of increased market efficiency. Hedge funds......(read more)
What Do Hedge Funds Have To Say About These 3 Purchases?
Most hedge funds and other money managers tracked by Insider Monkey have not submitted their 13F filings for the September quarter just yet. These public......(read more)
The Proxy Battle Between Broadfin Capital and Cardica (CRDC) Is Heating Up Just As New CEO Is Unveiled
The battle between Broadfin Capital and the Board of Cardica, Inc. (NASDAQ:CRDC) is heating up. As promised in a recent letter, Broadfin Capital and manager......(read more)
Hedge Funds See More Upside for Nevro Corp (NVRO) and WidePoint Corporation (WYY)
According to a recent 13G form filed with the Securities and Exchange Commission Kevin Kotler‘s (pictured) Broadfin Capital has added 1.18 million......(read more)
Contentious Proxy Battle Looms Between Broadfin Capital And Cardica, Inc. (CRDC)
Kevin Kotler‘s healthcare fund Broadfin Capital, the top performing fund in our database this year based on the calculated returns of its public......(read more)
Next Big Biotech Stock To Buy: Hedge Funds’ New Moves
Both Antares Pharma Inc (NASDAQ:ATRS) and Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) recently had their names attached to 13G forms, as two hedge......(read more)
Broadfin Capital Increases Its Profitable Stake In Advaxis Inc. (ADXS) To 5.27%
As disclosed in a Schedule 13G filing with the U.S. Securities and Exchange Commission, Kevin Kotler’s Broadfin Capital holds an ownership stake of......(read more)
Broadfin Capital and Bridger Management Think SeaSpine Holdings Corp (SPNE) Is Oversold
According to two recent filings with the Securities and Exchange Commission, Kevin Kotler‘s (pictured) Broadfin Capital and Roberto Mignone‘......(read more)
Healthcare Expert Kevin Kotler Boosts His Stake In Recro Pharma Inc. (REPH)
Kevin Kotler’s Broadfin Capital has filed a 13D with the Securities and Exchange Commission regarding its stake in Recro Pharma Inc. (NASDAQ:REPH).......(read more)
Broadfin Capital Discloses New Stake in This Canadian Biotechnology Company
Broadfin Capital, led by Kevin Kotler, has initiated a new position in QLT Inc. (USA) (NASDAQ:QLTI). In a new filing with the U.S. Securities and Exchange......(read more)
Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths
According to a recent 13G form filed with the Securities and Exchange Commission, Kevin Kotler‘s Broadfin Capital has initiated a stake in ContraFect......(read more)
Hedge Fund News: Edward Lampert, Carl Icahn, Marc Lasry
Sears Canada Loss Narrows As Same-Store Sales Decline Slows (Reuters) Struggling department store chain Sears Canada Inc reported a smaller first-quarter......(read more)
Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross......(read more)
Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains
Kevin Kotler‘s Broadfin Capital has disclosed raising its passive stake in the micro-cap oncology biotechnology company Ignyta Inc (NASDAQ:RXDX).......(read more)
Broadfin Buffs Up on Zogenix, Inc. (ZGNX) and Derma Sciences Inc (DSCI)
In two separate filings today Kevin Kotler‘s Broadfin Capital has revealed increasing its passive stake in Zogenix, Inc. (NASDAQ:ZGNX) to 10.74......(read more)
Tonix Pharmaceuticals Holding Corp., Manning & Napier Inc: Deerfield, Ariel Open Bullish New Positions
James E. Flynn’s Deerfield Management entered a new position in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) this week. According to the 13G Form......(read more)
Epirus Biopharmaceuticals Inc (EPRS): These Two Funds Open New Positions
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over. In filings with the SEC that were revealed over the last......(read more)
Alcobra Ltd (ADHD): Broadfin Capital and Deerfield Initiate Passive Stakes Following Public Offering
Kevin Kotler’s Broadfin Capital and James Flynn’s Deerfield Management have both initiated passive stakes in Alcobra Ltd (NASDAQ:ADHD). As......(read more)
Digimarc Corp (DMRC), Eleven Biotherapeutics Inc (EBIO): Rima Senvest Management and Sabby Management Are Bullish on These Micro-Caps
Digimarc Corp (NASDAQ:DMRC) and Eleven Biotherapeutics Inc (NASDAQ:EBIO) are two companies on which two funds have been bullish recently. Richard Mashaal......(read more)
Dipexium Pharmaceuticals Inc (DPRX): Kingdon Capital Boosts Stake in Recently-Public Pharmaceutical Company
Mark Kingdon’s Kingdon Capital recently disclosed an increase in its exposure to Dipexium Pharmaceuticals Inc (NASDAQ:DPRX). Following the addition......(read more)
Aegerion Pharmaceuticals, Inc. (AEGR): Broadfin Boosts Stake Getting on Board with Other Bullish Investors
Kevin Kotler‘s New York-based fund Broadfin Capital has boosted its position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR). In a new filing with......(read more)
Cardica, Inc. (CRDC): Broadfin Capital Asks Other Shareholders to Support Its Crusade
Kevin Kotler’s Broadfin Capital doesn’t want to hear any more excuses from the Board of Cardica, Inc. (NASDAQ:CRDC) for under-performance, it want......(read more)
Aegerion Pharmaceuticals Inc. (AEGR), Cytori Therapeutics Inc (CYTX): Scopia Capital and Sabby Capital Are Bullish on These Stocks
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness. Not only did Steve Cohen’s Point72 Asset Management disclose......(read more)
PowerSecure International Inc. (POWR), Anthera Pharmaceuticals Inc (ANTH): Broadfin Capital and Becker Drapkin Management’s Recent Bullish Moves
Last Friday, Kevin Kotler’s Broadfin Capital disclosed a marked increase (of almost 70%) in its exposure to Anthera Pharmaceuticals Inc (NASDAQ:ANTH......(read more)
Servicesource International Inc (SREV), Recro Pharma Inc (REPH): Altai Capital And Broadfin Capital’s Latest Moves
According to a recent filing with the Securities and Exchange Commission, Altai Capital, run by Rishi Bajaj, Toby Symonds and Steve Tesoriere, has increased......(read more)
Cardica Inc. (CRDC): Broadfin Capital, Kevin Kotler Send Another Letter To The Board
In a recent filing with the Securities and Exchange Commission, Broadfin Capital has disclosed a letter sent to the Board of Directors of Cardica,......(read more)
Visium Asset Management Raises Exposure To Horizon Pharma Inc. (HZNP)
Visium Asset Management, managed by Jacob Gottlieb, has boosted its position in Horizon Pharma Inc. (NASDAQ:HZNP), a new filing with the U.S. Securities......(read more)
Kevin Kotler, Broadfin Capital Add Some More Cardica, Inc. (CRDC) Shares To Their Portfolio
Kevin Kotler and his fund, Broadfin Capital, have further boosted their holding of Cardica, Inc. (NASDAQ:CRDC) stock. According to a recent filing with......(read more)
